Pharmaceutical

China NMPA grants IND clearance for Fermion’s TYK2 JH2 inhibitor

The China NMPA has granted clearance for the investigational new drug (IND) application of Guangzhou Fermion Technology’s FZ007-119.

Feb 6, 2024 - 18:00
China NMPA grants IND clearance for Fermion’s TYK2 JH2 inhibitor
The China NMPA has granted clearance for the investigational new drug (IND) application of Guangzhou Fermion Technology’s FZ007-119.
Read the original article

Tags:

Previous Article

Mithra sets out plan to rescue cash runway

Next Article

J&J touts success of nipocalimab in two rare disease trials

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Just how much money do drugmakers gain from patent extensions?

STAT+: Just how much money do drugmakers gain from pate...

Sep 26, 2023

Ginkgo buys StrideBio’s AAV discovery and engineering platform assets

Ginkgo buys StrideBio’s AAV discovery and engineering p...

Apr 6, 2023

Gilead and Genesis partner to create novel therapies using AI

Gilead and Genesis partner to create novel therapies us...

Sep 12, 2024